Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion type Assertion NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_head.
- NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion description "[We demonstrate here for the first time that the ErbB3/4 ligand heregulin (HRG) reduced both ErbB2 and ErbB3 mRNA and protein levels in human breast cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_provenance.
- NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion evidence source_evidence_literature NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_provenance.
- NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion SIO_000772 24692179 NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_provenance.
- NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion wasDerivedFrom befree-20150227 NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_provenance.
- NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_assertion wasGeneratedBy ECO_0000203 NP380871.RA2noLlt4Z8bMGRv4xmqV0CEG3byORoc5SptDLI7iFDNY130_provenance.